February 23, 2018

Alfa Scientific Designs, Inc   
Naishu Wang   
CTO   
13200 Gregg Street   
Poway, CA 92064

Re: k173303 Trade/Device Name: INSTANT-VIEW plus Multi-Drug of Abuse Urine Test - Simple Cup (OTC Use) INSTANT-VIEW plus Multi-Drug Urine Test - Simple Cup (Prescription Use) Regulation Number: 21 CFR 862.3100 Regulation Name: Amphetamine test system Regulatory Class: Class II Product Code: DKZ, DIS, DJG, JXM, DIO, DJC, DJR, LCM, LFG, LDJ, DNK, NFT, PTH, NFV, NFY, NGG, PTG, NGM, NFW, NGI, NGL, QAW Dated: January 16, 2018 Received: January 22, 2018

Dear Naishu Wang:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801 and Part 809); medical device reporting (reporting of medical device-related adverse events) (21 CFR

803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice   
(https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/) and CDRH Learn   
(http://www.fda.gov/Training/CDRHLearn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (http://www.fda.gov/DICE) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).

Sincerely,

# Kellie B. Kelm -S

Courtney H. Lias, Ph.D.GPS Director Division of Chemistry and Toxicology Devices Office of In Vitro Diagnostics and Radiological Health Center for Devices and Radiological Health

Enclosure

510(k) Number (if known) k173303

Device Name INSTANT-VIEW plus Multi-Drug of Abuse Urine Test - Simple Cup (OTC Use)

Indications for Use (Describe)   
T STANT-VIEW plu MultDrugu rineTe Sml upOTCUseevic is api, qulive l human urine. The device can detect up to 13 drugs or their metabolites:

<table><tr><td>Analyte</td><td>Calibrator</td><td>Cutoff (ng/mL)</td></tr><tr><td>Amphetamines</td><td>d-Amphetamine</td><td>1000</td></tr><tr><td>Barbiturates</td><td>Secobarbital</td><td>200</td></tr><tr><td>Buprenorphine</td><td>Buprenorphine</td><td>10</td></tr><tr><td>Benzodiazepines</td><td>Oxazepam</td><td>300</td></tr><tr><td>Cocaine</td><td>Benzoylecgonine</td><td>300</td></tr><tr><td>Methamphetamine</td><td>d-Methamphetamine</td><td>1000</td></tr><tr><td>Methadone</td><td>Methadone</td><td>300</td></tr><tr><td>Phencyclidine</td><td>Phencyclidine</td><td>25</td></tr><tr><td>Tricyclic</td><td></td><td></td></tr><tr><td>Antidepressants</td><td>Nortriptyline</td><td>1000</td></tr><tr><td>Cannabinoids</td><td>11-nor-Δ9-THC-9-COOH</td><td>50</td></tr><tr><td>MDMA</td><td>Methylenedioxymethamphetamine</td><td>500</td></tr><tr><td>Morphine</td><td>Morphine</td><td>2000</td></tr><tr><td>Oxycodone</td><td>Oxycodone</td><td>300</td></tr></table>

T

T alylula e Cu u preliminary positive results are obtained.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

# O NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.\*

Te uren m olectionoationate veragours  oncud vitnsseah eit d sur ath nmia d eed  c and review he collection ofinformation. Send comments regarding this burden estimate o any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services

![](images/addb36d82d1bae19e157f0ac2d555f062770d7d03716a8f566a7cc41bd86db39.jpg)

510(k) Number (if known) k173303

Device Name INSTANT-VIEW plus Multi-Drug Urine Test - Simple Cup (Prescription Use)

Indications for Use (Describe)   
T NSTANT-VIEW plus MultrugUrineTesSml up resevic s rapi quave   
li   
human urine. The device can detect up to 13 drugs or their metabolites:

<table><tr><td>Analyte</td><td>Calibrator</td><td>Cutoff (ng/mL)</td></tr><tr><td>Amphetamines</td><td>d-Amphetamine</td><td>1000</td></tr><tr><td>Barbiturates</td><td>Secobarbital</td><td>200</td></tr><tr><td>Buprenorphine</td><td>Buprenorphine</td><td>10</td></tr><tr><td>Benzodiazepines</td><td>Oxazepam</td><td>300</td></tr><tr><td>Cocaine</td><td>Benzoylecgonine</td><td>300</td></tr><tr><td>Methamphetamine</td><td>d-Methamphetamine</td><td>1000</td></tr><tr><td>Methadone</td><td>Methadone</td><td>300</td></tr><tr><td>Phencyclidine</td><td>Phencyclidine</td><td>25</td></tr><tr><td>Tricyclic</td><td></td><td></td></tr><tr><td>Antidepressants</td><td>Nortriptyline</td><td>1000</td></tr><tr><td>Cannabinoids</td><td>11-nor-Δ9-THC-9-COOH</td><td>50</td></tr><tr><td>MDMA</td><td>Methylenedioxymethamphetamine</td><td>500</td></tr><tr><td>Morphine</td><td>Morphine</td><td>2000</td></tr><tr><td>Oxycodone</td><td>Oxycodone</td><td>300</td></tr></table>

.

T al/ C preliminary positive results are obtained.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

# \*DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.\*

T buren m olectioationat vegours nc eviewnsructions,searh exisng dat soures ather anmaintain he data neede d cople and review he collection nformation. Send comments regarding this burden estimate or anyothe aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

# 510(k) Summary

Safety and effectiveness as required by 21 CFR 807.92

# Manufacturer and Submitter

# Name:

Alfa Scientific Designs, Inc.

# Address:

13200 Gregg Street Poway, CA 92064 Telephone: 858-513-3888 Fax: 858-513-8388

# Contact Person:

Naishu Wang, MD, PhD Email: wnss@alfascientific.com

# Device Name

# Trade Name:

INSTANT-VIEW plus Multi-Drug of Abuse Urine Test - Simple Cup (OTC Use) INSTANT-VIEW plus Multi-Drug Urine Test - Simple Cup (Prescription Use)

# Common Name:

Immunoassay, Drug of Abuse Screening Urine Test

# Classification Name:

Amphetamine Test System, Barbiturate Test System, Benzodiazepine Test System, Cocaine and Cocaine Metabolite Test System, Methamphetamine Test System, Morphine Test System, Cannabinoid Test System, Methadone Test System, Tricyclic Antidepressant Drugs Test System, Phencyclidine Test System, Opiate Test System

<table><tr><td rowspan=1 colspan=1>Analyte</td><td rowspan=1 colspan=1>RegulationNumber</td><td rowspan=1 colspan=1>Product code(OTC use)</td><td rowspan=1 colspan=1>Product code(prescription use)</td></tr><tr><td rowspan=1 colspan=1>Amphetamines</td><td rowspan=1 colspan=1>862.3100</td><td rowspan=1 colspan=1>NFT</td><td rowspan=1 colspan=1>DKZ</td></tr><tr><td rowspan=1 colspan=1>Barbiturates</td><td rowspan=1 colspan=1>862.3150</td><td rowspan=1 colspan=1>PTH</td><td rowspan=1 colspan=1>DIS</td></tr><tr><td rowspan=1 colspan=1>Buprenorphine</td><td rowspan=1 colspan=1>862.3650</td><td rowspan=1 colspan=1>NGL</td><td rowspan=1 colspan=1>DJG</td></tr><tr><td rowspan=1 colspan=1>Benzodiazepines</td><td rowspan=1 colspan=1>862.3170</td><td rowspan=1 colspan=1>NFV</td><td rowspan=1 colspan=1>JXM</td></tr><tr><td rowspan=1 colspan=1>Cocaine</td><td rowspan=1 colspan=1>862.3250</td><td rowspan=1 colspan=1>NFY</td><td rowspan=1 colspan=1>DIO</td></tr><tr><td rowspan=1 colspan=1>Methamphetamine</td><td rowspan=1 colspan=1>862.3610</td><td rowspan=1 colspan=1>NGG</td><td rowspan=1 colspan=1>DJC</td></tr><tr><td rowspan=1 colspan=1>Methadone</td><td rowspan=1 colspan=1>862.3620</td><td rowspan=1 colspan=1>PTG</td><td rowspan=1 colspan=1>DJR</td></tr><tr><td rowspan=1 colspan=1>Phencyclidine</td><td rowspan=1 colspan=1>unclassified</td><td rowspan=1 colspan=1>NGM</td><td rowspan=1 colspan=1>LCM</td></tr><tr><td rowspan=1 colspan=1>TricyclicAntidepressants</td><td rowspan=1 colspan=1>862.3910</td><td rowspan=1 colspan=1>QAW</td><td rowspan=1 colspan=1>LFG</td></tr><tr><td rowspan=1 colspan=1>Cannabinoids</td><td rowspan=1 colspan=1>862.3870</td><td rowspan=1 colspan=1>NFW</td><td rowspan=1 colspan=1>LDJ</td></tr><tr><td rowspan=1 colspan=1>MDMA</td><td rowspan=1 colspan=1>862.3610</td><td rowspan=1 colspan=1>NGG</td><td rowspan=1 colspan=1>DJC</td></tr><tr><td rowspan=1 colspan=1>Morphine</td><td rowspan=1 colspan=1>862.3640</td><td rowspan=1 colspan=1>NGI</td><td rowspan=1 colspan=1>DNK</td></tr><tr><td rowspan=1 colspan=1>Oxycodone</td><td rowspan=1 colspan=1>862.3650</td><td rowspan=1 colspan=1>NGL</td><td rowspan=1 colspan=1>DJG</td></tr></table>

# Date of Preparation

# Predicate Devices

# k152122 Instant-View Multi-Drug Urine Test Cup (Home Use), Instant-View Multi-Drug Urine Test Panel (Home Use)

# Device Description

These devices are one-step lateral flow chromatographic immunoassays consisting of any combination of one (1) to thirteen (13) individual test strip(s). Each test strip in the device consists of 1) a conjugate pad containing colloidal gold coupled with the anti-drug antibodies and 2) nitrocellulose membrane containing a test line (T line) coated with the conjugated drug antigen and a control line (C line). The C line serves as an internal quality control of the system and appears as a burgundy-colored band during the test regardless of the presence of the drug.

# Intended Use

The INSTANT-VIEW plus Multi-Drug of Abuse Urine Test - Simple Cup (OTC Use) device is a rapid, qualitative immunoassay device for the detection of one or more drugs or metabolites at the designated cutoff concentrations in human urine. The device can detect up to 13 drugs or their metabolites:

<table><tr><td rowspan=1 colspan=1>Analyte</td><td rowspan=1 colspan=1>Calibrator</td><td rowspan=1 colspan=1>Cutoff (ng/mL)</td></tr><tr><td rowspan=1 colspan=1>Amphetamines</td><td rowspan=1 colspan=1>d-Amphetamine</td><td rowspan=1 colspan=1>1000</td></tr><tr><td rowspan=1 colspan=1>Barbiturates</td><td rowspan=1 colspan=1>Secobarbital</td><td rowspan=1 colspan=1>200</td></tr><tr><td rowspan=1 colspan=1>Buprenorphine</td><td rowspan=1 colspan=1>Buprenorphine</td><td rowspan=1 colspan=1>10</td></tr><tr><td rowspan=1 colspan=1>Benzodiazepines</td><td rowspan=1 colspan=1>Oxazepam</td><td rowspan=1 colspan=1>300</td></tr><tr><td rowspan=1 colspan=1>Cocaine</td><td rowspan=1 colspan=1>Benzoylecgonine</td><td rowspan=1 colspan=1>300</td></tr><tr><td rowspan=1 colspan=1>Methamphetamine</td><td rowspan=1 colspan=1>d-Methamphetamine</td><td rowspan=1 colspan=1>1000</td></tr><tr><td rowspan=1 colspan=1>Methadone</td><td rowspan=1 colspan=1>Methadone</td><td rowspan=1 colspan=1>300</td></tr><tr><td rowspan=1 colspan=1>Phencyclidine</td><td rowspan=1 colspan=1>Phencyclidine</td><td rowspan=1 colspan=1>25</td></tr><tr><td rowspan=1 colspan=1>Tricyclic Antidepressants</td><td rowspan=1 colspan=1>Nortriptyline</td><td rowspan=1 colspan=1>1000</td></tr><tr><td rowspan=1 colspan=1>Cannabinoids</td><td rowspan=1 colspan=1>11-nor-Δ9-THC-9-COOH</td><td rowspan=1 colspan=1>50</td></tr><tr><td rowspan=1 colspan=1>MDMA</td><td rowspan=1 colspan=1>Methylenedioxy-methamphetamine</td><td rowspan=1 colspan=1>500</td></tr><tr><td rowspan=1 colspan=1>Morphine</td><td rowspan=1 colspan=1>Morphine</td><td rowspan=1 colspan=1>2000</td></tr><tr><td rowspan=1 colspan=1>Oxycodone</td><td rowspan=1 colspan=1>Oxycodone</td><td rowspan=1 colspan=1>300</td></tr></table>

These assays may yield positive results when barbiturates, benzodiazepines, or tricyclic antidepressants are ingested at or above therapeutic doses. There are no uniformly recognized cutoff levels for barbiturates, benzodiazepines, or tricyclic antidepressants in urine. The assays are not intended to distinguish between prescription use or abuse of these drugs.

This device provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Chromatography/mass spectrometry is the preferred confirmatory method. Clinical

consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are obtained.

The INSTANT-VIEW plus Multi-Drug Urine Test - Simple Cup (Prescription Use) device is a rapid, qualitative immunoassay device for the detection of one or more drugs or metabolites at the designated cutoff concentrations in human urine. The device can detect up to 13 drugs or their metabolites:

<table><tr><td rowspan=1 colspan=1>Analyte</td><td rowspan=1 colspan=1>Calibrator</td><td rowspan=1 colspan=1>Cutoff (ng/mL)</td></tr><tr><td rowspan=1 colspan=1>Amphetamines</td><td rowspan=1 colspan=1>d-Amphetamine</td><td rowspan=1 colspan=1>1000</td></tr><tr><td rowspan=1 colspan=1>Barbiturates</td><td rowspan=1 colspan=1>Secobarbital</td><td rowspan=1 colspan=1>200</td></tr><tr><td rowspan=1 colspan=1>Buprenorphine</td><td rowspan=1 colspan=1>Buprenorphine</td><td rowspan=1 colspan=1>10</td></tr><tr><td rowspan=1 colspan=1>Benzodiazepines</td><td rowspan=1 colspan=1>Oxazepam</td><td rowspan=1 colspan=1>300</td></tr><tr><td rowspan=1 colspan=1>Cocaine</td><td rowspan=1 colspan=1>Benzoylecgonine</td><td rowspan=1 colspan=1>300</td></tr><tr><td rowspan=1 colspan=1>Methamphetamine</td><td rowspan=1 colspan=1>d-Methamphetamine</td><td rowspan=1 colspan=1>1000</td></tr><tr><td rowspan=1 colspan=1>Methadone</td><td rowspan=1 colspan=1>Methadone</td><td rowspan=1 colspan=1>300</td></tr><tr><td rowspan=1 colspan=1>Phencyclidine</td><td rowspan=1 colspan=1>Phencyclidine</td><td rowspan=1 colspan=1>25</td></tr><tr><td rowspan=1 colspan=1>Tricyclic Antidepressants</td><td rowspan=1 colspan=1>Nortriptyline</td><td rowspan=1 colspan=1>1000</td></tr><tr><td rowspan=1 colspan=1>Cannabinoids</td><td rowspan=1 colspan=1>11-nor-Δ9-THC-9-COOH</td><td rowspan=1 colspan=1>50</td></tr><tr><td rowspan=1 colspan=1>MDMA</td><td rowspan=1 colspan=1>Methylenedioxy-methamphetamine</td><td rowspan=1 colspan=1>500</td></tr><tr><td rowspan=1 colspan=1>Morphine</td><td rowspan=1 colspan=1>Morphine</td><td rowspan=1 colspan=1>2000</td></tr><tr><td rowspan=1 colspan=1>Oxycodone</td><td rowspan=1 colspan=1>Oxycodone</td><td rowspan=1 colspan=1>300</td></tr></table>

These assays may yield positive results when barbiturates, benzodiazepines, or tricyclic antidepressants are ingested at or above therapeutic doses. There are no uniformly recognized cutoff levels for barbiturates, benzodiazepines, or tricyclic antidepressants in urine. The assays are not intended to distinguish between prescription use or abuse of these drugs.

This device provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Chromatography/mass spectrometry is the preferred confirmatory method. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are obtained.

# Comparison to Predicate Devices

<table><tr><td rowspan=1 colspan=3>Similarities</td></tr><tr><td rowspan=1 colspan=1>Item</td><td rowspan=1 colspan=1>Device</td><td rowspan=1 colspan=1>Predicate</td></tr><tr><td rowspan=1 colspan=1>Intended Use</td><td rowspan=1 colspan=1>Same</td><td rowspan=1 colspan=1>Qualitative detection ofdrugs of abuse in urine</td></tr><tr><td rowspan=1 colspan=1>Test Principle</td><td rowspan=1 colspan=1>Same</td><td rowspan=1 colspan=1>Lateral flowimmunochromatographic</td></tr><tr><td rowspan=1 colspan=1>Matrix</td><td rowspan=1 colspan=1>Same</td><td rowspan=1 colspan=1>Urine</td></tr><tr><td rowspan=1 colspan=1>Number of strips per device</td><td rowspan=1 colspan=1>Same</td><td rowspan=1 colspan=1>1  13 depending uponconfiguration</td></tr><tr><td rowspan=1 colspan=1>Analyte cutoffs (ng/mL)</td><td rowspan=1 colspan=1>Same</td><td rowspan=1 colspan=1>AMP - 1000BAR - 200BUP - 10BZD- 300COC-300MDMA - 500MET - 1000MTD- 300MOR - 2000OXY-300PCP -25TCA - 1000THC - 50</td></tr><tr><td rowspan=1 colspan=1>Shelf life</td><td rowspan=1 colspan=1>Same</td><td rowspan=1 colspan=1>24 months</td></tr></table>

<table><tr><td rowspan=1 colspan=3>Differences</td></tr><tr><td rowspan=1 colspan=1>Item</td><td rowspan=1 colspan=1>Device</td><td rowspan=1 colspan=1>Predicate</td></tr><tr><td rowspan=1 colspan=1>Sample application procedure</td><td rowspan=1 colspan=1>User urinates into cupand urine contacts thetest strips immediately.</td><td rowspan=1 colspan=1>User urinates into cup, butthe urine sample does notcontact test strips until aknob is pushed, allowingthe sample to flow to thebottom of the cup.</td></tr><tr><td rowspan=1 colspan=1>Storage conditions</td><td rowspan=1 colspan=1>Same</td><td rowspan=1 colspan=1>15°-30° C</td></tr></table>

# Performance Characteristics

To assess precision, each analyte was tested at the following concentrations: Negative, $- 7 5 \%$ , $- 5 0 \%$ , $- 2 5 \%$ , cutoff, $+ 2 5 \%$ , $+ 5 0 \%$ , $+ 7 5 \%$ , and $+ 1 0 0 \%$ of the cutoff for each analyte. The panels were blinded and randomized prior to testing. Testing was performed using three lots of test strips and was performed by 10 operators over ten non- consecutive days, and the results of this testing are summarized as follows for each analyte.

Amphetamines   

<table><tr><td rowspan=1 colspan=1>Conc(ng/mL)</td><td rowspan=1 colspan=1>% ofcutoff</td><td rowspan=1 colspan=1>Results(Neg/Pos)Lot 1</td><td rowspan=1 colspan=1>Results(Neg/Pos)Lot 2</td><td rowspan=1 colspan=1>Results(Neg/Pos)Lot 3</td></tr><tr><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td></tr><tr><td rowspan=1 colspan=1>250</td><td rowspan=1 colspan=1>-75%</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td></tr><tr><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>-50%</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td></tr><tr><td rowspan=1 colspan=1>750</td><td rowspan=1 colspan=1>-25%</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td></tr><tr><td rowspan=1 colspan=1>1000</td><td rowspan=1 colspan=1>cutoff</td><td rowspan=1 colspan=1>2/48</td><td rowspan=1 colspan=1>1/49</td><td rowspan=1 colspan=1>1/49</td></tr><tr><td rowspan=1 colspan=1>1250</td><td rowspan=1 colspan=1>+25%</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td></tr><tr><td rowspan=1 colspan=1>1500</td><td rowspan=1 colspan=1>+50%</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td></tr><tr><td rowspan=1 colspan=1>1750</td><td rowspan=1 colspan=1>+75%</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td></tr><tr><td rowspan=1 colspan=1>2000</td><td rowspan=1 colspan=1>+100%</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td></tr></table>

Barbiturates   

<table><tr><td rowspan=1 colspan=1>Conc(ng/mL)</td><td rowspan=1 colspan=1>% ofcutoff</td><td rowspan=1 colspan=1>Results(Neg/Pos)Lot 1</td><td rowspan=1 colspan=1>Results(Neg/Pos)Lot 2</td><td rowspan=1 colspan=1>Results(Neg/Pos)Lot 3</td></tr><tr><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td></tr><tr><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>-75%</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td></tr><tr><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>-50%</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td></tr><tr><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>-25%</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td></tr><tr><td rowspan=1 colspan=1>200</td><td rowspan=1 colspan=1>cutoff</td><td rowspan=1 colspan=1>1/49</td><td rowspan=1 colspan=1>3/47</td><td rowspan=1 colspan=1>2/48</td></tr><tr><td rowspan=1 colspan=1>250</td><td rowspan=1 colspan=1>+25%</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td></tr><tr><td rowspan=1 colspan=1>300</td><td rowspan=1 colspan=1>+50%</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td></tr><tr><td rowspan=1 colspan=1>350</td><td rowspan=1 colspan=1>+75%</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td></tr><tr><td rowspan=1 colspan=1>400</td><td rowspan=1 colspan=1>+100%</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td></tr></table>

Buprenorphine   

<table><tr><td rowspan=1 colspan=1>Conc(ng/mL)</td><td rowspan=1 colspan=1>% ofcutoff</td><td rowspan=1 colspan=1>Results(Neg/Pos)Lot 1</td><td rowspan=1 colspan=1>Results(Neg/Pos)Lot 2</td><td rowspan=1 colspan=1>Results(Neg/Pos)Lot 3</td></tr><tr><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td></tr><tr><td rowspan=1 colspan=1>2.5</td><td rowspan=1 colspan=1>-75%</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td></tr><tr><td rowspan=1 colspan=1>5</td><td rowspan=1 colspan=1>-50%</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td></tr><tr><td rowspan=1 colspan=1>7.5</td><td rowspan=1 colspan=1>-25%</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td></tr><tr><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>cutoff</td><td rowspan=1 colspan=1>1/49</td><td rowspan=1 colspan=1>2/48</td><td rowspan=1 colspan=1>2/48</td></tr><tr><td rowspan=1 colspan=1>12.5</td><td rowspan=1 colspan=1>+25%</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td></tr><tr><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>+50%</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td></tr><tr><td rowspan=1 colspan=1>17.5</td><td rowspan=1 colspan=1>+75%</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td></tr><tr><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>+100%</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td></tr></table>

Benzodiazepines   

<table><tr><td rowspan=1 colspan=1>Conc(ng/mL)</td><td rowspan=1 colspan=1>% ofcutoff</td><td rowspan=1 colspan=1>Results(Neg/Pos)Lot 1</td><td rowspan=1 colspan=1>Results(Neg/Pos)Lot 2</td><td rowspan=1 colspan=1>Results(Neg/Pos)Lot 3</td></tr><tr><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td></tr><tr><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>-75%</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td></tr><tr><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>-50%</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td></tr><tr><td rowspan=1 colspan=1>225</td><td rowspan=1 colspan=1>-25%</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td></tr><tr><td rowspan=1 colspan=1>300</td><td rowspan=1 colspan=1>cutoff</td><td rowspan=1 colspan=1>2/48</td><td rowspan=1 colspan=1>2/48</td><td rowspan=1 colspan=1>2/48</td></tr><tr><td rowspan=1 colspan=1>375</td><td rowspan=1 colspan=1>+25%</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td></tr><tr><td rowspan=1 colspan=1>450</td><td rowspan=1 colspan=1>+50%</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td></tr><tr><td rowspan=1 colspan=1>525</td><td rowspan=1 colspan=1>+75%</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td></tr><tr><td rowspan=1 colspan=1>600</td><td rowspan=1 colspan=1>+100%</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td></tr></table>

Cocaine   

<table><tr><td rowspan=1 colspan=1>Conc(ng/mL)</td><td rowspan=1 colspan=1>% ofcutoff</td><td rowspan=1 colspan=1>Results(Neg/Pos)Lot 1</td><td rowspan=1 colspan=1>Results(Neg/Pos)Lot 2</td><td rowspan=1 colspan=1>Results(Neg/Pos)Lot 3</td></tr><tr><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td></tr><tr><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>-75%</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td></tr><tr><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>-50%</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td></tr><tr><td rowspan=1 colspan=1>225</td><td rowspan=1 colspan=1>-25%</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td></tr><tr><td rowspan=1 colspan=1>300</td><td rowspan=1 colspan=1>cutoff</td><td rowspan=1 colspan=1>1/49</td><td rowspan=1 colspan=1>2/48</td><td rowspan=1 colspan=1>1/49</td></tr><tr><td rowspan=1 colspan=1>375</td><td rowspan=1 colspan=1>+25%</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td></tr><tr><td rowspan=1 colspan=1>450</td><td rowspan=1 colspan=1>+50%</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td></tr><tr><td rowspan=1 colspan=1>525</td><td rowspan=1 colspan=1>+75%</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td></tr><tr><td rowspan=1 colspan=1>600</td><td rowspan=1 colspan=1>+100%</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td></tr></table>

Methamphetamine   

<table><tr><td rowspan=1 colspan=1>Conc(ng/mL)</td><td rowspan=1 colspan=1>% ofcutoff</td><td rowspan=1 colspan=1>Results(Neg/Pos)Lot 1</td><td rowspan=1 colspan=1>Results(Neg/Pos)Lot 2</td><td rowspan=1 colspan=1>Results(Neg/Pos)Lot 3</td></tr><tr><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td></tr><tr><td rowspan=1 colspan=1>250</td><td rowspan=1 colspan=1>-75%</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td></tr><tr><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>-50%</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td></tr><tr><td rowspan=1 colspan=1>750</td><td rowspan=1 colspan=1>-25%</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td></tr><tr><td rowspan=1 colspan=1>1000</td><td rowspan=1 colspan=1>cutoff</td><td rowspan=1 colspan=1>1/49</td><td rowspan=1 colspan=1>2/48</td><td rowspan=1 colspan=1>1/49</td></tr><tr><td rowspan=1 colspan=1>1250</td><td rowspan=1 colspan=1>+25%</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td></tr><tr><td rowspan=1 colspan=1>1500</td><td rowspan=1 colspan=1>+50%</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td></tr><tr><td rowspan=1 colspan=1>1750</td><td rowspan=1 colspan=1>+75%</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td></tr><tr><td rowspan=1 colspan=1>2000</td><td rowspan=1 colspan=1>+100%</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td></tr></table>

Methadone   

<table><tr><td rowspan=1 colspan=1>Conc(ng/mL)</td><td rowspan=1 colspan=1>% ofcutoff</td><td rowspan=1 colspan=1>Results(Neg/Pos)Lot 1</td><td rowspan=1 colspan=1>Results(Neg/Pos)Lot 2</td><td rowspan=1 colspan=1>Results(Neg/Pos)Lot 3</td></tr><tr><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td></tr><tr><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>-75%</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td></tr><tr><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>-50%</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td></tr><tr><td rowspan=1 colspan=1>225</td><td rowspan=1 colspan=1>-25%</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td></tr><tr><td rowspan=1 colspan=1>300</td><td rowspan=1 colspan=1>cutoff</td><td rowspan=1 colspan=1>2/48</td><td rowspan=1 colspan=1>2/48</td><td rowspan=1 colspan=1>2/48</td></tr><tr><td rowspan=1 colspan=1>375</td><td rowspan=1 colspan=1>+25%</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td></tr><tr><td rowspan=1 colspan=1>450</td><td rowspan=1 colspan=1>+50%</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td></tr><tr><td rowspan=1 colspan=1>525</td><td rowspan=1 colspan=1>+75%</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td></tr><tr><td rowspan=1 colspan=1>600</td><td rowspan=1 colspan=1>+100%</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td></tr></table>

Phencyclidine   

<table><tr><td rowspan=1 colspan=1>Conc(ng/mL)</td><td rowspan=1 colspan=1>% ofcutoff</td><td rowspan=1 colspan=1>Results(Neg/Pos)Lot 1</td><td rowspan=1 colspan=1>Results(Neg/Pos)Lot 2</td><td rowspan=1 colspan=1>Results(Neg/Pos)Lot 3</td></tr><tr><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td></tr><tr><td rowspan=1 colspan=1>6.25</td><td rowspan=1 colspan=1>-75%</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td></tr><tr><td rowspan=1 colspan=1>12.5</td><td rowspan=1 colspan=1>-50%</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td></tr><tr><td rowspan=1 colspan=1>18.75</td><td rowspan=1 colspan=1>-25%</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td></tr><tr><td rowspan=1 colspan=1>25</td><td rowspan=1 colspan=1>cutoff</td><td rowspan=1 colspan=1>1/49</td><td rowspan=1 colspan=1>2/48</td><td rowspan=1 colspan=1>2/48</td></tr><tr><td rowspan=1 colspan=1>31.25</td><td rowspan=1 colspan=1>+25%</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td></tr><tr><td rowspan=1 colspan=1>37.5</td><td rowspan=1 colspan=1>+50%</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td></tr><tr><td rowspan=1 colspan=1>43.75</td><td rowspan=1 colspan=1>+75%</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td></tr><tr><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>+100%</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td></tr></table>

Tricyclic Antidepressants   

<table><tr><td rowspan=1 colspan=1>Conc(ng/mL)</td><td rowspan=1 colspan=1>% ofcutoff</td><td rowspan=1 colspan=1>Results(Neg/Pos)Lot 1</td><td rowspan=1 colspan=1>Results(Neg/Pos)Lot 2</td><td rowspan=1 colspan=1>Results(Neg/Pos)Lot 3</td></tr><tr><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td></tr><tr><td rowspan=1 colspan=1>250</td><td rowspan=1 colspan=1>-75%</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td></tr><tr><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>-50%</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td></tr><tr><td rowspan=1 colspan=1>750</td><td rowspan=1 colspan=1>-25%</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td></tr><tr><td rowspan=1 colspan=1>1000</td><td rowspan=1 colspan=1>cutoff</td><td rowspan=1 colspan=1>3/47</td><td rowspan=1 colspan=1>2/48</td><td rowspan=1 colspan=1>1/49</td></tr><tr><td rowspan=1 colspan=1>1250</td><td rowspan=1 colspan=1>+25%</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td></tr><tr><td rowspan=1 colspan=1>1500</td><td rowspan=1 colspan=1>+50%</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td></tr><tr><td rowspan=1 colspan=1>1750</td><td rowspan=1 colspan=1>+75%</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td></tr><tr><td rowspan=1 colspan=1>2000</td><td rowspan=1 colspan=1>+100%</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td></tr></table>

Cannabinoids   

<table><tr><td rowspan=1 colspan=1>Conc(ng/mL)</td><td rowspan=1 colspan=1>% ofcutoff</td><td rowspan=1 colspan=1>Results(Neg/Pos)Lot 1</td><td rowspan=1 colspan=1>Results(Neg/Pos)Lot 2</td><td rowspan=1 colspan=1>Results(Neg/Pos)Lot 3</td></tr><tr><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td></tr><tr><td rowspan=1 colspan=1>12.5</td><td rowspan=1 colspan=1>-75%</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td></tr><tr><td rowspan=1 colspan=1>25</td><td rowspan=1 colspan=1>-50%</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td></tr><tr><td rowspan=1 colspan=1>37.5</td><td rowspan=1 colspan=1>-25%</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td></tr><tr><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>cutoff</td><td rowspan=1 colspan=1>1/49</td><td rowspan=1 colspan=1>1/49</td><td rowspan=1 colspan=1>1/49</td></tr><tr><td rowspan=1 colspan=1>62.5</td><td rowspan=1 colspan=1>+25%</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td></tr><tr><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>+50%</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td></tr><tr><td rowspan=1 colspan=1>87.5</td><td rowspan=1 colspan=1>+75%</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td></tr><tr><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>+100%</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td></tr></table>

MDMA   

<table><tr><td rowspan=1 colspan=1>Conc(ng/mL)</td><td rowspan=1 colspan=1>% ofcutoff</td><td rowspan=1 colspan=1>Results(Neg/Pos)Lot 1</td><td rowspan=1 colspan=1>Results(Neg/Pos)Lot 2</td><td rowspan=1 colspan=1>Results(Neg/Pos)Lot 3</td></tr><tr><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td></tr><tr><td rowspan=1 colspan=1>125</td><td rowspan=1 colspan=1>-75%</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td></tr><tr><td rowspan=1 colspan=1>250</td><td rowspan=1 colspan=1>-50%</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td></tr><tr><td rowspan=1 colspan=1>375</td><td rowspan=1 colspan=1>-25%</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td></tr><tr><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>cutoff</td><td rowspan=1 colspan=1>3/47</td><td rowspan=1 colspan=1>2/48</td><td rowspan=1 colspan=1>2/48</td></tr><tr><td rowspan=1 colspan=1>625</td><td rowspan=1 colspan=1>+25%</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td></tr><tr><td rowspan=1 colspan=1>750</td><td rowspan=1 colspan=1>+50%</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td></tr><tr><td rowspan=1 colspan=1>875</td><td rowspan=1 colspan=1>+75%</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td></tr><tr><td rowspan=1 colspan=1>1000</td><td rowspan=1 colspan=1>+100%</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td></tr></table>

Morphine   

<table><tr><td rowspan=1 colspan=1>Conc(ng/mL)</td><td rowspan=1 colspan=1>% ofcutoff</td><td rowspan=1 colspan=1>Results(Neg/Pos)Lot 1</td><td rowspan=1 colspan=1>Results(Neg/Pos)Lot 2</td><td rowspan=1 colspan=1>Results(Neg/Pos)Lot 3</td></tr><tr><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td></tr><tr><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>-75%</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td></tr><tr><td rowspan=1 colspan=1>1000</td><td rowspan=1 colspan=1>-50%</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td></tr><tr><td rowspan=1 colspan=1>1500</td><td rowspan=1 colspan=1>-25%</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td></tr><tr><td rowspan=1 colspan=1>2000</td><td rowspan=1 colspan=1>cutoff</td><td rowspan=1 colspan=1>2/48</td><td rowspan=1 colspan=1>1/49</td><td rowspan=1 colspan=1>2/48</td></tr><tr><td rowspan=1 colspan=1>2500</td><td rowspan=1 colspan=1>+25%</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td></tr><tr><td rowspan=1 colspan=1>3000</td><td rowspan=1 colspan=1>+50%</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td></tr><tr><td rowspan=1 colspan=1>3500</td><td rowspan=1 colspan=1>+75%</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td></tr><tr><td rowspan=1 colspan=1>4000</td><td rowspan=1 colspan=1>+100%</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td></tr></table>

Oxycodone   

<table><tr><td rowspan=1 colspan=1>Conc(ng/mL)</td><td rowspan=1 colspan=1>% ofcutoff</td><td rowspan=1 colspan=1>Results(Neg/Pos)Lot 1</td><td rowspan=1 colspan=1>Results(Neg/Pos)Lot 2</td><td rowspan=1 colspan=1>Results(Neg/Pos)Lot 3</td></tr><tr><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td></tr><tr><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>-75%</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td></tr><tr><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>-50%</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td></tr><tr><td rowspan=1 colspan=1>225</td><td rowspan=1 colspan=1>-25%</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td></tr><tr><td rowspan=1 colspan=1>300</td><td rowspan=1 colspan=1>cutoff</td><td rowspan=1 colspan=1>2/48</td><td rowspan=1 colspan=1>2/48</td><td rowspan=1 colspan=1>2/48</td></tr><tr><td rowspan=1 colspan=1>375</td><td rowspan=1 colspan=1>+25%</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td></tr><tr><td rowspan=1 colspan=1>450</td><td rowspan=1 colspan=1>+50%</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td></tr><tr><td rowspan=1 colspan=1>525</td><td rowspan=1 colspan=1>+75%</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td></tr><tr><td rowspan=1 colspan=1>600</td><td rowspan=1 colspan=1>+100%</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td></tr></table>

A lay user study was also performed. A total of four-hundred (400) participants were recruited, and each participant was provided one (1) package insert, one (1) blind labeled test solution, and one (1) test device. Test solutions were randomly picked for participants, one for each. Every participant was requested to read the provided materials, perform the testing, and then filled out the forms. Participants recruited were with diverse educational backgrounds and ranged in age from 18 to ${ > } 6 0$ . Results were as follows:

<table><tr><td rowspan=1 colspan=1>Drug(cutoffng/ml)</td><td rowspan=1 colspan=1>CutoffConcentration%(ng/ml)</td><td rowspan=1 colspan=1>Numberofsamples</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=4 colspan=1>AMP(1000)</td><td rowspan=1 colspan=1>0% (0)</td><td rowspan=1 colspan=1>350</td><td rowspan=1 colspan=1>350</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>75% (750)</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>1</td></tr><tr><td rowspan=1 colspan=1>125% (1250)</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>9</td></tr><tr><td rowspan=1 colspan=1>150% (1500)</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>30</td></tr><tr><td rowspan=4 colspan=1>BAR(200)</td><td rowspan=1 colspan=1>0% (0)</td><td rowspan=1 colspan=1>350</td><td rowspan=1 colspan=1>350</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>75% (150)</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>1</td></tr><tr><td rowspan=1 colspan=1>125% (250)</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>9</td></tr><tr><td rowspan=1 colspan=1>150% (300)</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>30</td></tr><tr><td rowspan=5 colspan=1>BUP(10)</td><td rowspan=1 colspan=1>0% (0)</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>50% (5)</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>75% (7.5)</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>57</td><td rowspan=1 colspan=1>3</td></tr><tr><td rowspan=1 colspan=1>125% (12.5)</td><td rowspan=1 colspan=1>120</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>111</td></tr><tr><td rowspan=1 colspan=1>150% (15)</td><td rowspan=1 colspan=1>140</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>140</td></tr><tr><td rowspan=4 colspan=1>BZD(300)</td><td rowspan=1 colspan=1>0% (0)</td><td rowspan=1 colspan=1>350</td><td rowspan=1 colspan=1>350</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>75% (225)</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>1</td></tr><tr><td rowspan=1 colspan=1>125% (375)</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>9</td></tr><tr><td rowspan=1 colspan=1>150% (450)</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>30</td></tr><tr><td rowspan=4 colspan=1>COC(300)</td><td rowspan=1 colspan=1>0% (0)</td><td rowspan=1 colspan=1>350</td><td rowspan=1 colspan=1>350</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>75% (225)</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>1</td></tr><tr><td rowspan=1 colspan=1>125% (375)</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>10</td></tr><tr><td rowspan=1 colspan=1>150% (450)</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>30</td></tr><tr><td rowspan=4 colspan=1>MET(1000)</td><td rowspan=1 colspan=1>0% (0)</td><td rowspan=1 colspan=1>350</td><td rowspan=1 colspan=1>350</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>75% (750)</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>1</td></tr><tr><td rowspan=1 colspan=1>125% (1250)</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>9</td></tr><tr><td rowspan=1 colspan=1>150% (1500)</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>30</td></tr><tr><td rowspan=4 colspan=1>MTD(300)</td><td rowspan=1 colspan=1>0% (0)</td><td rowspan=1 colspan=1>350</td><td rowspan=1 colspan=1>350</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>75% (225)</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>8</td><td rowspan=1 colspan=1>2</td></tr><tr><td rowspan=1 colspan=1>125% (375)</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>10</td></tr><tr><td rowspan=1 colspan=1>150% (450)</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>30</td></tr><tr><td rowspan=4 colspan=1>PCP(25)</td><td rowspan=1 colspan=1>0% (0)</td><td rowspan=1 colspan=1>350</td><td rowspan=1 colspan=1>350</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>75% (18.75)</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>125% (31.25)</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>9</td></tr><tr><td rowspan=1 colspan=1>150% (37.5)</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>30</td></tr><tr><td rowspan=4 colspan=1>TCA(1000)</td><td rowspan=1 colspan=1>0% (0)</td><td rowspan=1 colspan=1>350</td><td rowspan=1 colspan=1>350</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>75% (750)</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>1</td></tr><tr><td rowspan=1 colspan=1>125% (1250)</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>9</td></tr><tr><td rowspan=1 colspan=1>150% (1500)</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>30</td></tr></table>

Surveys and labeling assessments   

<table><tr><td rowspan=4 colspan=1>THC(50)</td><td rowspan=1 colspan=1>0% (0)</td><td rowspan=1 colspan=1>350</td><td rowspan=1 colspan=1>350</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>75% (37.5)</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>125% (62.5)</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>8</td></tr><tr><td rowspan=1 colspan=1>150% (75)</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>30</td></tr><tr><td rowspan=4 colspan=1>XTC(MDMA)(500)</td><td rowspan=1 colspan=1>0% (0)</td><td rowspan=1 colspan=1>350</td><td rowspan=1 colspan=1>350</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>75% (37.5)</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>125% (625)</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>9</td></tr><tr><td rowspan=1 colspan=1>150% (750)</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>30</td></tr><tr><td rowspan=4 colspan=1>MOR(2000)</td><td rowspan=1 colspan=1>0% (0)</td><td rowspan=1 colspan=1>350</td><td rowspan=1 colspan=1>350</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>75% (1500)</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>125% (2500)</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>8</td></tr><tr><td rowspan=1 colspan=1>150% (3000)</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>30</td></tr><tr><td rowspan=4 colspan=1>OXY(300)</td><td rowspan=1 colspan=1>0% (0)</td><td rowspan=1 colspan=1>350</td><td rowspan=1 colspan=1>350</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>75% (225)</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>125% (375)</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>8</td></tr><tr><td rowspan=1 colspan=1>150% (450)</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>30</td></tr></table>

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Very easy tounderstand</td><td rowspan=1 colspan=1>Easy tounderstand</td><td rowspan=1 colspan=1>Understandw/ somedifficulty</td><td rowspan=1 colspan=1>Difficult orimpossible tounderstand</td></tr><tr><td rowspan=1 colspan=1>Explanationof intendeduse of the test</td><td rowspan=1 colspan=1>171(42.75%)</td><td rowspan=1 colspan=1>215(53.75%)</td><td rowspan=1 colspan=1>14(3.5%)</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>Directions todo the test</td><td rowspan=1 colspan=1>226(59%)</td><td rowspan=1 colspan=1>163(40.75%)</td><td rowspan=1 colspan=1>11(2.75%)</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>Performingthe test</td><td rowspan=1 colspan=1>186(46.5%)</td><td rowspan=1 colspan=1>202(50.5%)</td><td rowspan=1 colspan=1>12(3%)</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>Direction tointerpret theresults</td><td rowspan=1 colspan=1>246(61.5%)</td><td rowspan=1 colspan=1>151(37.75%)</td><td rowspan=1 colspan=1>13(32.5%)</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>Actualinterpretationof the testresults</td><td rowspan=1 colspan=1>182(45.5%)</td><td rowspan=1 colspan=1>212(53%)</td><td rowspan=1 colspan=1>16(4%)</td><td rowspan=1 colspan=1>0</td></tr></table>

# Conclusion

The INSTANT-VIEW plus Multi-Drug of Abuse Urine Test - Simple Cup (OTC Use) and INSTANT-VIEW plus Multi-Drug Urine Test - Simple Cup (Prescription Use) are substantially equivalent to the predicate device.